ES376759A1 - Nicotinate esters - Google Patents

Nicotinate esters

Info

Publication number
ES376759A1
ES376759A1 ES376759A ES376759A ES376759A1 ES 376759 A1 ES376759 A1 ES 376759A1 ES 376759 A ES376759 A ES 376759A ES 376759 A ES376759 A ES 376759A ES 376759 A1 ES376759 A1 ES 376759A1
Authority
ES
Spain
Prior art keywords
compound
hypolipaemic
agents
nicotinate esters
diuza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES376759A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of ES376759A1 publication Critical patent/ES376759A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions with hypolipaemic activity when administered orally or parenterally comprise a compound I in which the wavy line indicates that said compound may be in either configuration and a diluent or carrier and optionally further hypolipaemic agents, hypocholesterolaemic agents, e.g. 22, 25-diuza-19-nor-cholestan-1,3,5(10)- trien-3-ol and/or anticoagulants such as phenylindane-dione.
ES376759A 1969-02-21 1970-02-20 Nicotinate esters Expired ES376759A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR6904459A FR2035754A1 (en) 1969-02-21 1969-02-21

Publications (1)

Publication Number Publication Date
ES376759A1 true ES376759A1 (en) 1972-05-16

Family

ID=9029434

Family Applications (1)

Application Number Title Priority Date Filing Date
ES376759A Expired ES376759A1 (en) 1969-02-21 1970-02-20 Nicotinate esters

Country Status (7)

Country Link
AT (1) AT292001B (en)
BE (1) BE746237A (en)
CH (1) CH523252A (en)
DE (1) DE2007948A1 (en)
ES (1) ES376759A1 (en)
FR (1) FR2035754A1 (en)
GB (1) GB1244453A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168389B (en) * 1981-05-06 1987-05-20 Alfa Farmaceutici Spa ALCANDIOL DERIVATIVES WITH HYPOLIPIDEMIZING ACTIVITY, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM

Also Published As

Publication number Publication date
DE2007948A1 (en) 1970-09-17
AT292001B (en) 1971-08-10
FR2035754A1 (en) 1970-12-24
CH523252A (en) 1972-05-31
BE746237A (en) 1970-08-19
GB1244453A (en) 1971-09-02

Similar Documents

Publication Publication Date Title
CA942753A (en) 5-azaspiro (2,4) heptane-4,6-diones
ES376759A1 (en) Nicotinate esters
CA966840A (en) 2-cyclohexenyl or 1,2,5,6-tetrahydropyridyl-5-alkyl-resorcinols
CA922315A (en) .alpha.-AMINO-2,4,6-CYCLOHEPTATRIENYL-METHYLCEPHALOSPORINS
CA935154A (en) 2,2'-diacylamino-1,1'-dianthraquinonyls
GB1122994A (en) Diuretic compositions
CA634429A (en) 2,6-bis-(2-hydroxy-1-naphthylmethyl)-4-alkylphenols
CA933931A (en) 1,3,4-thiadiazolone-(5)-yl-(2)-ureas
CA766748A (en) 1,4-PREGNADIENE-17.alpha.,21-DIOL-3,11,20-TRIONE 17,21-DIACYLATE
CA858561A (en) 2,4-DIBROMOPREGNANE-17.alpha.,21-DIOL-3,11,20-TRIONE-21-ACYLATE
CA827694A (en) 3,3'-dithiobis(3-azabicyclo(3.2.2)nonane)
AU1650470A (en) 1, 1'methylene-bis-piperazine
AU456901B2 (en) TETRAHYDRO-2H-INDENO 1,2-o PYRIDINES
CA851179A (en) 17.alpha.-ACYLOXY-6.alpha.-METHYL-16-METHYLENEPREGN-4-ENE-3,20-DIONES
AU285565B2 (en) Pharmaceutical compositions comprising 2 or 4 - amino - 3,5 dihlobenzylamines
CA751482A (en) 2,3,6-trichloro-5-nitrobenzoic acid and the salts thereof
CA679753A (en) 17.alpha.-BROMO-6.alpha.-FLUOROPROGESTERONE AND PROCESS FOR THE PREPARATION THEREOF
CA777823A (en) Process for the preparation of tricyclo (3.3.2.04,6)deca-2,7,9-triene
CA811144A (en) 6.alpha.,16.alpha.-DIMETHYL-17.alpha.-HYDROXYPROGESTERONE
AU285651B2 (en) 2, 2' bipyridine pharmaceutical compositions
AU289663B2 (en) 2, 4-DIAMINO-7-CHLOROPYRIDS (2, 3-d) PYRIMIDINES AND PHARMACEUTICAL COMPOSITIONS
CA839733A (en) Cyanofluoropyridines and fungicidal compositions and methods for using the same
CA855234A (en) 2-substituted 2,3-dihydrobenzofurans
CA922316A (en) .alpha.-UREIDO-2,4,6-CYCLOHEPTATRIENYL-METHYLCEPHALOSPORINS
CA859131A (en) 17-OXYGENATED-5.alpha.-ANDROSTANE-2.alpha.,3.alpha.-EPISULFIDES